TODD STRATEGY GROUP

Lobbying for NOVO NORDISK INC. · Pharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Implementation of Inflation Reduction Act. Pharmacy Benefit Manager Reform, Health care supply chain. 340B. Treat and Reduce Obesity Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.